Site Map

 
Web Page 
Home
 
Category 
About us
Web Page 
About Us
Web Page 
Management
Web Page 
Board Of Directors
Web Page 
Experts
 
Category 
CellDetect
Web Page 
CellDetect®
Web Page 
Bladder Cancer
Web Page 
Cervical Cancer
Web Page 
Prostate Cancer
 
Category 
BRONJ Test
Web Page 
BRONJ Test
 
Category 
Investors
Web Page 
Investors
Web Page 
About Micromedic
Category 
News & Events
Web Page 
Invitation to general assembly meeting
Web Page 
Micromedic Announces routine use of CellDetect in additional CLIA Laboratory in the US
Web Page 
Micromedic announces distribution agreement in Germany
Web Page 
Micromedic announces significant purchase order from China
Web Page 
Announcement of the annual general assembly of shareholders of Micromedic Technologies
Web Page 
An extraordinary assembly of Micromedic's shareholders is scheduled on January 3rd, 2017 at 4pm in the Company's offices in Kyriat Atidim
Web Page 
Micromedic announces approval to conduct an extended clinical study with CellDetect on prostate cancer diagnosis
Web Page 
Announcement of an extraordinary assembly of shareholders of Micromedic Technologies
Web Page 
Announcement of the annual general assembly of shareholders of Micromedic Technologies
Web Page 
Micromedic Announces Receipt of Regulatory Approval to Commercialize CellDetect® Bladder Cancer Monitoring Kit in Israel
Web Page 
Micromedic Announces Cooperation with Axella Research for Financing and Execution of Clinical and Regulatory Activities Required for FDA Approval of CellDetect® Bladder Cancer Monitoring
Web Page 
Micromedic Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of BRONJ
Web Page 
Micromedic Obtains EU CE Mark for CellDetect® Non-Invasive Test for Detecting Recurrence of Bladder Cancer
Web Page 
Micromedic Reports Successful Clinical Study Results for Monitoring Bladder Cancer Recurrence
Web Page 
Micromedic Reports Successful Interim Results from Bladder Cancer Clinical Study
Web Page 
Micromedic identifies new genetic markers to predict risk of developing BRONJ
Web Page 
Micromedic reports success in clinical pilot of its Cervical Cancer diagnostic product in a central hospital in Beijing
Web Page 
Zetiq has signed a memorandum of understanding for collaboration in India
Web Page 
Successful interim results in a trial of a test for recurrence of bladder cancer cells in urine specimens
Web Page 
Zetiq receives patent approval in Japan for its cell staining technology
Web Page 
Marketing approval for Zetiq's CellDetect in China
Web Page 
BioLight will invest 4 million NIS for additional 5% of Micromedic
Web Page 
Micromedic signed an investment agreement with BioMarCare Technologies Inc.
Web Page 
BioLight acquires 21% of Micromedic
Web Page 
Stock Quotes
 
Web Page 
Contact us
 
Web Page 
Site Map
 
Web Page 
International
 
Web Page 
USA
 
 

 

© Micromedic Technologies Ltd. site mapcontact
 
Site by Site2goal | Design Studio Michal Lehavi